A pig kidney transplant that has been working in a person for 271 days has set a new world record in xenotransplantation and gives new hope for the many thousands of people waiting for organ donations. This was part of a clinical trial that closely observed a pig kidney that was used temporarily as a bridge to maintain the patient until a human transplant could be performed. The patient received a kidney from a genetically engineered pig, with the goal of eliminating the canine-to-human immediate rejection. Scientists had altered various genes in the donor animal to make the organ seem less foreign to the human immune system.
Following the operation, the kidney immediately started dialling and regulating fluids. Medical professionals monitored this new organ to closely while it operated well beyond the only a few weeks or months of prior experiments. For end-stage kidney failure communities the story has significant implications. Dialysis may save lives but it consumes hours each week and slowly deteriorates the human constitution.
A functioning transplant brings back independence and vitality in not many years. The human organ shortage remains critical. Waiting lists in many places exceed a decade, while thousands die in the interim. A dependable pig kidney would provide a pragmatic alternative in the absence of a human donor. The 271-result was not a coincidence. The investigators dedicated several years to optimize the six gene edits, perfect the surgical procedure and obtain the right anti rejection cocktail. In standard operating room, the kidney was attached to the patient’s vasculatures and urinary systems.
Blood analyses, imagining scans and biopsies monitored any index of inflammation or rejection. As soon as the organ showed first signs of fatigue, the human kidney was available, and the canulation was performed aseptically. The original authors call the pig organ a ‘bridge’ rather than a solely temporary solution. Yet, the duration of function achieved so far indicates more extended function may not lie too far in the future.
The next generation of bespoke kidney may work for a number of years rather than months. This changes the debate from a crisis of organ shortage to one of planning ahead. Also, the research built knowledge on the in vivo response of the human to the transplanted animal tissue.
The levels of immune cells, antibodies and inflammation were tracked in real-time. These results will inform the next set of gene edits and drugs. Every successful experiment decreases the uncertainties experienced by surgeons and patients: the public debate about pig organ transplants tends to blend enthusiasm and caution. Some individuals are wary of swapping one species’ organ for another’s.
Other individuals are concerned about the treatment of donor animals and about establishing robust safety measures. The scientists involved stress that the animals are raised under controlled conditions and that the genetic alteration involves no more than editing for compatibility. Also, openly reporting both successes and failures in the gene altering process encourages trust from the public.